Choroid Plexus Neoplasms: Clinical Trials

7 trials for Choroid Plexus Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated, 2 completed, 1 unknown. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Terminated 4, Completed 2, Unknown 1

Follow Choroid Plexus Neoplasms: new trials by email Literature Review of Choroid Plexus Neoplasms trials Research Report on Choroid Plexus Neoplasms

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
filgrastim - Childhood Choroid Plexus Tumor, Childhood Medulloblastoma
Phase 3TerminatedBarbara Ann Karmanos Cancer Institute232013-08-012020-10-29
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
cyproheptadine hydrochloride, placebo - Cancer
Phase 3TerminatedUniversity of South Florida222010-06-012015-07-02
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
Carboplatin, Cisplatin, Cyclophosphamide - Brain Cancer, Choroid Plexus Tumors
Phase 3TerminatedTufts Medical Center272009-11-012019-08-20
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
donepezil hydrochloride, Placebo - Brain Tumors, Metastatic Disease
Phase 3CompletedWake Forest University Health Sciences1982008-02-012021-10-20
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Treatment of Tumors of the Choroid Plexus Epithelium
Carboplatin, Cyclophosphamide, Etoposide - Choroid Plexus Tumors
Phase 3TerminatedM.D. Anderson Cancer Center22005-09-022020-02-27
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
carboplatin, cisplatin, cyclophosphamide - Brain and Central Nervous System Tumors
Phase 3UnknownChildren's Hospital Los Angeles1202004-03-012013-12-18

Narrower conditions

Astrocytoma (4)  ·  Medulloblastoma (4)  ·  Oligodendroglioma (4)  ·  Brain Neoplasms (3)  ·  Glioblastoma (3)  ·  Osteosarcoma (3)  ·  Chondrosarcoma (2)  ·  Craniopharyngioma (2)  ·  Ependymoma (2)  ·  Glioma (2)  ·  Glioma, Subependymal (2)  ·  Gliosarcoma (2)  ·  Lymphoma, Large-Cell, Anaplastic (2)  ·  Meningioma (2)

Broader conditions

Brain Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Cerebral Ventricle Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Nervous System Diseases (7)  ·  Nervous System Neoplasms (7)  ·  Central Nervous System Neoplasms (6)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Germ Cell and Embryonal (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Neoplasms, Nerve Tissue (5)  ·  Neuroectodermal Tumors (5)  ·  Brain Neoplasms (4)  ·  Neoplasms, Complex and Mixed (4)

Interventions

Carboplatin (3)  ·  Cyclophosphamide (3)  ·  Etoposide (3)  ·  Vincristine (3)  ·  Cisplatin (2)  ·  Methotrexate (2)  ·  Radiotherapy (2)  ·  Temozolomide (2)  ·  Cyproheptadine (1)  ·  Dactinomycin (1)  ·  Donepezil (1)  ·  Doxorubicin (1)  ·  Fentanyl (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)

Sponsors

Barbara Ann Karmanos Cancer Institute (1)  ·  Children's Hospital Los Angeles (1)  ·  INSYS Therapeutics Inc (1)  ·  M.D. Anderson Cancer Center (1)  ·  Tufts Medical Center (1)  ·  University of South Florida (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (7)  ·  New Zealand (2)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  Hungary (1)  ·  Switzerland (1)

Top investigators

Girish Dhall, MD (1)  ·  Jeffrey P. Krischer, PhD (1)  ·  Johannes Wolff, MD (1)  ·  Jonathan L. Finlay, MB, ChB (1)  ·  Kelley Haley, RN, BSN (1)  ·  Larry Dillaha, MD (1)  ·  Maxim Yankelevich (1)  ·  Michael E. Rytting, MD (1)  ·  Stephen Rapp, PhD (1)

Results publications

PMID 19543851, PMID 22480131, PMID 27020837

NIH funding

P30CA022453 (1), U10CA081851 (1), U10CA081920 (1)